TrialCirculation journal : official journal of the Japanese Circulation Society2017

One-Year Efficacy and Safety of Evolocumab in Japanese Patients　- A Pooled Analysis From the Open-Label Extension OSLER Studies.

Atsushi Hirayama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.